Top Markets
Coin of the day
Arch Biopartners Inc. Arch Biopartners Inc.

Arch Biopartners Inc.

ARCH
Ранг среди акций #25408
Arch Biopartners Inc. is a biotechnology firm dedicated to devising... Arch Biopartners Inc. is a biotechnology firm dedicated to devising groundbreaking solutions for both medical and commercial applications. A significant focus for the company is the advancement of Metablok, a key therapeutic agent designed to address or avert dipeptidase-1 driven inflammation in critical organs such as the lungs, liver, and kidneys. This inflammatory response can lead to profound organ dysfunction or complete failure, particularly in conditions like sepsis and COVID-19. Moreover, Arch Biopartners is developing AB569, an experimental medication intended to combat antibiotic-resistant bacterial infections, primarily through topical application on wounds. Their innovative product pipeline also features Borg, a specialized peptide-solid surface interface developed to hinder biofilm formation and lessen material corrosion. Lastly, MetaMx involves synthetic compounds engineered to target the cells that initiate brain tumors and invasive glioma cells. The company's operations are based out of Toronto, Canada.
Цена акции
$0.73393689
Последняя синхронизация: 2026-08-20
Рыночная капитализация
$49.86M
Изменение (1 день)
-8.26%
Изменение (1 год)
-38.15%
Страна
CA
Торговля Arch Biopartners Inc. (ARCH)

Категория

История цены акций Arch Biopartners Inc. (ARCH)
Наивысшая цена закрытия: $0.80 2026-08-01

Наименьшая цена закрытия: $0.24 2010-05-01
История цены акций Arch Biopartners Inc. с 2010 по 2026
Годовая динамика цены акций
Год Результативность
2026 (TTM) -23.16%
2025 -30.82%
2024 20.19%
2023 -48.03%
2022 -33.91%
2021 176.41%
2020 54.21%
2019 -26.71%
2018 185.93%
2017 8.76%
2016 42.45%
2015 -21.16%
2014 48.45%
2013 -6.69%
2012 -40.44%
2011 -46.45%
2010 0.00%
Цена акций похожих компаний или конкурентов
Компания Цена акций Изменение 1г% Страна
$539.14 35.65%
US
$1.04K 56.21%
NL
$118.33 -18.49%
AU
$761.87 8.65%
CH
$130.43 397.46%
US